WAT
Waters Corporation (NYSE: WAT) announced that the BD BACTEC FXI Culture System has received CE marking...
Article Summary
HOLD- Waters Corporation (NYSE: WAT) announced that the BD BACTEC FXI Culture System has received CE marking under the European Union's In Vitro Diagnostic Regulation enabling commercialization in Europe, representing a key milestone in Waters's clinical microbiology portfolio expansion.
- The next-generation, fully automated blood culture system is designed to improve speed, consistency, and accuracy of bloodstream infection diagnostics in modern microbiology laboratories, delivering a mean time to detection approximately three hours faster than the previous generation BD B ACTEC FX System, supporting earlier detection of pathogens and more timely initiation of targeted antimicrobial therapy in patients with suspected bloodstream infections and sepsis.
- The system features automated gravimetric measurement of individual blood culture vial volume, the first-of-its-kind capability in a blood culture platform, offering industry-leading automated loading capacity of up to 60 vials at a time, reducing manual intervention and significantly increasing walkaway time.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 7.0% | 25% | 35.0 ptsBelow Screener (7.0%) - Weak growth |
| EPS Growth Next 5Y ? | 11.2% | 25% | 35.0 ptsBelow Screener (11.2%) - Modest outlook |
| Target Price Upside ? | 17.1% | 20% | 60.0 ptsModerate Upside (17.1%) - Target: $387.24 vs Current: $330.60 |
| Gross Margin % ? | 57.8% | 15% | 80.0 ptsVery Healthy (57.8%) - High-quality margins |
| Drawdown from 52-Wk High ? | -20.2% | 15% | 40.0 ptsMild Pullback (-20.2%) - Light entry opportunity |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About WAT
- Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
- The company operates through two segments, Waters and TA.
- The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
- It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
- In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.
- Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.
- The company was founded in 1958 and is headquartered in Milford, Massachusetts.